Terpineol
CAS 562-74-3
Terpineol (CAS 562-74-3) is a pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 624.375 ug.mL-1 | 16 | - |
| - | IC50 | 30000 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| 4-TERPINEOL, (+/-)- | 1314261 | SU | MTHSPL |
| TERPINEOL | 1368180 | SU | MTHSPL |
| Terpineol | 1368180 | SU | MTHSPL |
| terpineol | 1368180 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Terpineol used for in pharmaceutical contexts?
Terpineol (CAS 562-74-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Terpineol?
No adverse-event association or SIDER side-effect rows are rendered for Terpineol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Terpineol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for 4-Terpineol (Terpinen-4-ol) with EU status "permitted".
What clinical phase is Terpineol in?
No phase 1-4 clinical development badge is rendered for Terpineol because the matched compound identifier rows do not contain a max-phase value.